Patents by Inventor Martina Schinke-Braun

Martina Schinke-Braun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
    Publication number: 20120114744
    Abstract: The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2.
    Type: Application
    Filed: January 18, 2012
    Publication date: May 10, 2012
    Applicant: NOVARTIS AG
    Inventors: Iwan BEUVINK, Jonathan HALL, Jan WEILER, Christian SCHNELL, Matthias MUELLER, Martina SCHINKE-BRAUN, Fabrizio SERLUCA
  • Compositions and Methods to Treat Muscular & Cardiovascular Disorders
    Publication number: 20120041052
    Abstract: The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2.
    Type: Application
    Filed: August 9, 2011
    Publication date: February 16, 2012
    Applicant: NOVARTIS AG
    Inventors: Iwan BEUVINK, Jonathan HALL, Jan WEILER, Christian Rene SCHNELL, Matthias MUELLER, Martina SCHINKE-BRAUN, Fabrizio SERLUCA
  • COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
    Publication number: 20100280094
    Abstract: The present invention relates to a novel microRNA, mir-208-2, implicated in muscular and cardiovascular disorders. The present invention also relates to oligonucleotide therapeutic agents (antisense oligonucleotides and/or double stranded oligonucleotides such as dsRNA) and their use in the treatment of muscular and cardiovascular disorders resulting from dysregulation of mir-208-2.
    Type: Application
    Filed: December 13, 2007
    Publication date: November 4, 2010
    Inventors: Iwan Beuvink, Jonathan Hall, Jan Weiler, Christian Schnell, Mathias Mueller, Martina Schinke-Braun, Fabrizio Serluca